russ2000_2_0167|CRNX|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0167|CRNX|1|Crinetics Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Inventories (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Book Value (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Crinetics Pharmaceuticals Inc EV to Revenues|Crinetics Pharmaceuticals Inc EV to Earnings|Crinetics Pharmaceuticals Inc EV to Free Cash Flow|Crinetics Pharmaceuticals Inc EV to Assets (Quarterly)|Crinetics Pharmaceuticals Inc PS Ratio|Crinetics Pharmaceuticals Inc PE Ratio|Crinetics Pharmaceuticals Inc Price to Book Value|Crinetics Pharmaceuticals Inc PEG Ratio|Crinetics Pharmaceuticals Inc Debt to Equity Ratio|Crinetics Pharmaceuticals Inc Dividend Yield|Crinetics Pharmaceuticals Inc Shareholder Yield (TTM)|Crinetics Pharmaceuticals Inc Percent of Shares Outstanding Short|Crinetics Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Return on Invested Capital|Crinetics Pharmaceuticals Inc Quality Ratio Score|Crinetics Pharmaceuticals Inc Momentum Score|Crinetics Pharmaceuticals Inc Beta (1Y)|Crinetics Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Crinetics Pharmaceuticals Inc Institutional Investor Ownership Percentage|Crinetics Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Crinetics Pharmaceuticals Inc Total Employees (Annual)|Crinetics Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Shares Outstanding|Crinetics Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Crinetics Pharmaceuticals Inc Payout Ratio|Crinetics Pharmaceuticals Inc Quick Ratio (Quarterly)|Crinetics Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Effective Tax Rate (TTM)|Crinetics Pharmaceuticals Inc Return on Equity|Crinetics Pharmaceuticals Inc Net Income (TTM) (USD)|Crinetics Pharmaceuticals Inc Revenue (TTM) (USD)|Crinetics Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Revenue (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Crinetics Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Net Income (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Crinetics Pharmaceuticals Inc Price (USD)|Crinetics Pharmaceuticals Inc Total Return Price (USD)|Crinetics Pharmaceuticals Inc Enterprise Value (USD)|Crinetics Pharmaceuticals Inc 30-Day Average Daily Volume|Crinetics Pharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0167|CRNX|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0167|CRNX|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
russ2000_2_0167|CRNX|5|91.2|91.2|0|91.2|0|91.2|91.2|91.2|0|91.2|91.2|0|1.4375|91.2857142857|1.44|91.2857142857|1.4375|0|1.44252873563|1.43913043478|91.2222222222|1.44755244755|91.3333333333|15.2307692308|91.2|91.2|91.2|91.3333333333|0|30.4615384615|30.5|91.3333333333|0|91.3076923077|183|91.3076923077|35.8571428571|91.375|91.2|91.2222222222|91.2222222222|91.3076923077|91.375|0|91.3333333333|91.2|91|0|91.3333333333|0|91.3076923077|91.3076923077|91.3076923077|91.3076923077|1.44755244755|1.44755244755|1.44|1.44935543278|1.44236760125||
russ2000_2_0167|CRNX|6|10|10|0|10|0|10|10|10|0|10|10|0|240|7|575|7|240|0|522|460|9|572|6|52|10|10|10|6|0|13|14|6|0|13|3|13|21|8|10|9|9|13|8|0|6|10|5|0|12|0|13|13|13|13|572|572|575|543|321||
russ2000_2_0167|CRNX|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
russ2000_2_0167|CRNX|201703||||||||||||||||||||||||||||||||||13.8782||-0.1878||||||-0.1878|||||||0.045||0.589|-2.606|-2.606|0.005|||||||
russ2000_2_0167|CRNX|201706||||||||||||||||||||||||||||||||||13.8782||-0.1187||||||-0.1187|||||||0.832||0.392|-1.648|-1.648|0.004|||||||
russ2000_2_0167|CRNX|201709||||||||||||||||||||||||||||||||||13.8782||-0.1716||||||-0.1716|||||||0.64||0.491|-2.382|-2.382|0.004|||||||
russ2000_2_0167|CRNX|201712|15.165|14.192||0.4||30.62|0.897|29.723||-15.022|-16.265||||||||||0||||0.734|0.403|0.001|||||||13.8782||-0.1817|||22.008|0|16.6399|-0.1817||||-9.157|2.045||0.528||0.467|-2.521|-2.521|0.013|||||||
russ2000_2_0167|CRNX|201803|74.731|73.74||0.476||96.305|3.136|93.169||-19.976|-21.729||||||||||0||||0.738|1.335|0.002|||||||22.008||-0.2483|||22.008|0|23.7494|-0.2483||||-12.015|2.442||0.442||1.248|-5.464|-5.464|0.064|||||||
russ2000_2_0167|CRNX|201806|69.944|68.408||1.808||99.88|5.638|94.242||-25.177|-27.297||219.5937||-38.1762||194.7855||||0|0||0.4699|1.223|2.603|0.002|||||||22.008|34|-0.253|23.008|0|22.008|0|12.3503|-0.253|0|||-15.935|2.267||0.657||1.118|-5.568|-5.568|0.151|25.35|25.35|514.8448|231392.5667||30.87|
russ2000_2_0167|CRNX|201809|171.041|169.654||4.353||9.16|5.514|3.646||167.523|-34.885||238.5971|-24.547|-42.5626|2.9372|256.5659||3.4347||0|0|0|5.3598|0.51|1.398|0.024|-78.7756||||-78.7756||20.016||-0.38|24.035|0|24.035|0|30.8604|-0.38|-106.472||-78.7756|-21.141|2.175||0.548||1.732|-7.588|-7.588|0.534|26.74|26.74|573.9991|131916.5333||24.91|35.07
russ2000_2_0167|CRNX|201812|166.683|163.875||4.232||11.19|7.925|3.265||160.225|-43.38||229.695|-20.5679|-32.5403|3.2535|272.0235||4.5035|-0.2812|0|0|0|6.8873|1.924|5.265|203.544|-50.6684||||-50.6684||24.0605|47|-0.35|24.0605|0|24.0605|0|20.921|-0.35|0||-50.6684|-27.115|2.428||0.781||2.561|-8.495|-8.495|0.999|30.03|30.03|552.1771|63397.6667||26.28|23.9
russ2000_2_0167|CRNX|201903|159.115|157.212||7.148||14.369|8.818|5.551||152.394|-52.396||166.4451|-12.7709|-18.3775|2.3485|218.0711||3.3265|-0.2074|0|0|-19.3988|6.4928|0.84|2.003|204.645|-35.2503||||-35.2503||24.095||-0.37|24.115||24.115|0|17.9238|-0.37|0||-35.2503|-30.667|2.353||0.367||3.156|-9.016|-9.016|1.01|22.45|22.45|377.069|87229.3||25.1|26.51
russ2000_2_0167|CRNX|201906|147.758|144.974||6.891||13.048|7.75|5.298||142.101|-64.823||189.6485|-12.2555|-18.1448|2.9642|239.5332||3.9076|-0.2076|0|0|-17.5926|8.3994|0.565|2.705|206.69|-31.4253||4|0.6842|-31.4253||24.161||-0.51|24.1949|-0.059|24.1949|0|18.7792|-0.51|0.059||-31.4253|-37.526|||||3.06|-12.427|-12.427|0.96|24.72|24.72|439.4843|65380.9|-11.9132|22.03|15.86
russ2000_2_0167|CRNX|201909|135.404|131.673||6.605||12.986|7.882|5.104||129.523|-79.253|||-5.2417|-6.906|1.6319|||2.5596|-0.1056|0|0|0.0162|8.1334|1.048|2.113|208.578|-29.5092||2|0.6119|-29.5092||24.208||-0.6|24.218|0|24.218|0|16.8385|-0.6|0||-29.5092|-44.368|||0.505||3.911|-14.43|-14.43|0.835|15.13|15.13|221.172|75519.4333|-44.2408|17.14|19.56
russ2000_2_0167|CRNX|201912|123.339|118.392||6.456||13.238|8.34|4.898||117.139|-93.802|||-9.7253|-11.3296|3.7612|||5.1969|-0.175|0|0|0.0097|7.5982|1.153|5.498|210.793|-35.9447||2|0.3244|-35.9447||24.235|68|-0.6|24.2631|0|24.2631|0|14.3339|-0.6|0||-35.9447|-50.422|||0.321||3.392|-14.549|-14.549|0.655|24|24|449.6622|68725.8|-20.0799|21.48|20.58
russ2000_2_0167|CRNX|202003|117.168|112.802||6.216||15.447|10.76|4.687||108.437|-111.162|||-4.2308|-5.3884|2.0069|||3.3331|-0.077|0|0|-1.7619|6.4268|1.221|8.296|219.432|-45.2329||4|1.5327|-45.2329||24.488||-0.71|24.587||24.587|0|10.5969|-0.71|-6.427||-45.2329|-58.766|||0.071||3.991|-17.36|-17.36|0.556|15.1|15.1|252.5682|66549.3333|-38.2192|17.78|17.62
russ2000_2_0167|CRNX|202006|210.61|205.165||6.012||14.348|9.87|4.478||202.774|-127.653|||-6.3119|-6.715|2.9942|||5.2705|-0.0918||0||7.7157|1.524|6.76|330.3|||3|1.6855|||31.409||-0.53|32.882|0|32.882|||-0.53|-108.078|||-62.83|||||4.322|-16.491|-16.491|0.26|17.52|17.52|370.9276|311466.2333|-23.294|14.6|15.53
russ2000_2_0167|CRNX|202009|194.122|186.824||5.695||13.095|8.833|4.262||187.222|-145.973|||-5.5993|-5.2689|2.6561|||2.4471|-0.0791||0||4.3037|1.769|4.69|333.151|||6|1.3693|||32.89||-0.56|32.921||32.921|||-0.56|0.222|||-66.72|||||4.752|-18.32|-18.32|0.122|15.09|15.09|291.0485|82048.1|4.1888|13.17|13.59
russ2000_2_0167|CRNX|202012|177.492|170.88||5.413||14.526|10.489|4.037||168.919|-167.614|||-5.0159|-4.087|2.3793|||2.3458|-0.0699||||4.368|1.833|5.588|336.508|||2|1.3589|||32.968|93|-0.66|33.0009||33.0009|||-0.66||||-73.812|||||4.961|-21.641|-21.641|0.053|13.09|13.09|244.1289|171639.5667|-42.2606|15.06|15.4
russ2000_2_0167|CRNX|202103|157.804|150.665||5.246||14.07|10.264|3.806||149.48|-190.515|||-6.0211|-5.4504|2.8562|||3.019|-0.0809||||4.5711|0.857|6.213|339.976|||1|1.2563|||33.012||-0.69|33.017||33.017|||-0.69||||-79.353|||||5.334|-22.901|-22.901|0.03|15.44|15.44|339.0862|118214.5333|3.9456|17.97|17.48
russ2000_2_0167|CRNX|202106|211.355|203.762||5.074||15.489|11.919|3.57||201.44|-216.61|||-8.6189|-8.1198|4.0885|||4.8161|-0.1003||||3.6141|1.044|7.145|418.04|||3|1.3245|||37.061||-0.7|37.6796||37.6796|||-0.7|-72.558|||-88.957|||||5.602|-26.095|-26.095|0.023|19.15|19.15|569.2486|233190.7|7.5913|17.66|23.57
russ2000_2_0167|CRNX|202109|203.973|193.325||4.886||15.769|12.44|3.329||193.59|-244.461|||-10.544|-8.0479|5.0017|||3.982|-0.109||||3.8442|1.04|6.153|438.063|||7|1.9551|||38.309||-0.73|38.62||38.62|||-0.73|-14.976|||-98.488|||||6.227|-27.851|-27.851|0.024|20.8|20.8|598.365|207009.3333|37.8396|23.69|27.32
russ2000_2_0167|CRNX|202112|||||||||||||||-13.2668||||6.6224|-0.1414||||2.7485||||||9|1.8727||||||||||||||||||||||||26.99|26.99|1156.1472|330352.9|102.3238|19|18.53